Adis Summary of Research: Number, duration, and distribution of wake bouts in patients with insomnia disorder: effect of daridorexant and zolpidem

The dual orexin receptor antagonist (DORA) daridorexant has been shown to improve objective sleep onset and maintenance in adults with insomnia disorder. This Adis Summary of Research summarises a report on an exploratory analysis that investigated the effect of daridorexant on the number, duration and distribution of night-time wake bouts, and their correlation with daytime functioning using data from two randomised controlled trials in adults with insomnia disorder.